GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Voronoi Inc (XKRX:310210) » Definitions » EV-to-EBIT

Voronoi (XKRX:310210) EV-to-EBIT : -23.01 (As of Jun. 20, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Voronoi EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Voronoi's Enterprise Value is ₩753,256.58 Mil. Voronoi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-32,730.63 Mil. Therefore, Voronoi's EV-to-EBIT for today is -23.01.

The historical rank and industry rank for Voronoi's EV-to-EBIT or its related term are showing as below:

XKRX:310210' s EV-to-EBIT Range Over the Past 10 Years
Min: -50.69   Med: -23.1   Max: -12.73
Current: -23.01

During the past 7 years, the highest EV-to-EBIT of Voronoi was -12.73. The lowest was -50.69. And the median was -23.10.

XKRX:310210's EV-to-EBIT is ranked worse than
100% of 438 companies
in the Biotechnology industry
Industry Median: 8.67 vs XKRX:310210: -23.01

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Voronoi's Enterprise Value for the quarter that ended in Mar. 2024 was ₩566,454.86 Mil. Voronoi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-32,730.63 Mil. Voronoi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -5.78%.


Voronoi EV-to-EBIT Historical Data

The historical data trend for Voronoi's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voronoi EV-to-EBIT Chart

Voronoi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - -22.83 -25.40

Voronoi Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.15 -28.12 -28.27 -25.40 -17.31

Competitive Comparison of Voronoi's EV-to-EBIT

For the Biotechnology subindustry, Voronoi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voronoi's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Voronoi's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Voronoi's EV-to-EBIT falls into.



Voronoi EV-to-EBIT Calculation

Voronoi's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=753256.579/-32730.634
=-23.01

Voronoi's current Enterprise Value is ₩753,256.58 Mil.
Voronoi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-32,730.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voronoi  (XKRX:310210) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Voronoi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-32730.634/566454.863
=-5.78 %

Voronoi's Enterprise Value for the quarter that ended in Mar. 2024 was ₩566,454.86 Mil.
Voronoi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-32,730.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voronoi EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Voronoi's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Voronoi (XKRX:310210) Business Description

Traded in Other Exchanges
N/A
Address
32 Songdo Gwawak-ro, 18th floor, S-dong, Yeonsu-gu, Incheon, KOR
Voronoi Inc is a biotech company that develops novel kinase inhibitors and targets protein degraders.

Voronoi (XKRX:310210) Headlines

No Headlines